benzoxazoles has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Li, Z; Liu, F; Wang, X; Zhang, Z; Zhuang, X | 1 |
1 other study(ies) available for benzoxazoles and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester
Article | Year |
---|---|
P-Glycoprotein (ABCB1) limits the brain distribution of YQA-14, a novel dopamine D3 receptor antagonist.
Topics: Acridines; Adenosine; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoxazoles; Blood-Brain Barrier; Brain; Caco-2 Cells; Dibenzocycloheptenes; Diketopiperazines; Dopamine Antagonists; Half-Life; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Permeability; Piperazines; Quinolines; ROC Curve; Temperature; Tetrahydroisoquinolines | 2015 |